Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) issued its earnings results on Tuesday. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.10), Zacks reports. The business had revenue of $10.96 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.46%. Bayer Aktiengesellschaft updated its FY 2024 guidance to 5.610-6.045 EPS.
Bayer Aktiengesellschaft Stock Down 3.9 %
Shares of OTCMKTS BAYRY traded down $0.22 during mid-day trading on Thursday, hitting $5.36. The company had a trading volume of 3,506,472 shares, compared to its average volume of 1,362,203. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 1.04. The firm has a 50-day simple moving average of $7.39 and a two-hundred day simple moving average of $7.42. The company has a market capitalization of $21.06 billion, a PE ratio of -20.62 and a beta of 1.10. Bayer Aktiengesellschaft has a one year low of $5.33 and a one year high of $11.33.
Wall Street Analyst Weigh In
Separately, Bank of America upgraded Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a research report on Friday, September 6th. One research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. According to data from MarketBeat, Bayer Aktiengesellschaft has an average rating of “Hold”.
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
- Five stocks we like better than Bayer Aktiengesellschaft
- What is the Euro STOXX 50 Index?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Invest in Biotech Stocks
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
